|

Strategic Targeting for Optimal Prevention of Cancer

RECRUITINGSponsored by ClinLogic LLC
Actively Recruiting
SponsorClinLogic LLC
Started2022-03-26
Est. completion2026-12-01
Eligibility
Age65 Years+
Healthy vol.Accepted
Locations1 site

Summary

The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.

Eligibility

Age: 65 Years+Healthy volunteers accepted
Inclusion Criteria:

* Study subjects may be included in the Clinical Trial if they meet all of the following inclusion criteria:

  * individuals, ages 65 years or older;
  * must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity;
  * hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations.
  * study subject has or had cancer
  * study subject has at least one family member with cirrent or past cancer

Exclusion Criteria:

* Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;

  * study subject is unable to provide an accurate history due to mental incapacity
  * study subject is currently abusing illicit and/or prescription drugs;

Conditions2

CancerEarly Detection of Cancer

Locations1 site

Sunbeam Clinical
Prosper, Texas, 75078
Kiran Asma

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.